These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 10396689)

  • 1. [Clinical and bacteriological evaluation of ceftriaxone (CTRX) dosed once daily in children with community-acquired pneumonia].
    Toyonaga Y; Kanemura H; Kitano M; Mitsui Y; Ishihara T; Hoshiai M; Ohno R
    Jpn J Antibiot; 1999 Apr; 52(4):322-32. PubMed ID: 10396689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical and bacteriological studies of ceftriaxone (CTRX) once daily administration in pediatric patients with respiratory tract infections].
    Hasui M; Kobayashi Y; Harada Y; Ono A; Okazaki H; Kino M; Hara T
    Jpn J Antibiot; 2001 Oct; 54(10):532-40. PubMed ID: 11771335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial activity and PK/PD of ceftriaxone against penicillin-resistant Streptococcus pneumoniae and beta-lactamase-negative ampicillin-resistant Haemophilus influenzae isolates from patients with community-acquired pneumonia.
    Ohno A; Ishii Y; Kobayashi I; Yamaguchi K
    J Infect Chemother; 2007 Oct; 13(5):296-301. PubMed ID: 17982717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation on ceftriaxone in the pediatric field].
    Nakazawa S; Satoh H; Niino K; Hirama Y; Narita A; Suzuki H; Nakazawa S; Chikaoka H; Tazoe K
    Jpn J Antibiot; 1984 Nov; 37(11):2083-101. PubMed ID: 6098703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antimicrobial activities of ceftriaxone against fresh, clinically isolated strains].
    Suzuki Y; Koguchi M; Tanaka S; Fukayama S; Ishihara R; Deguchi K; Oda S; Nakane Y; Fukumoto T
    Jpn J Antibiot; 1996 Jan; 49(1):83-94. PubMed ID: 8851307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bacteriological, pharmacokinetic and clinical evaluations of ceftriaxone in the pediatric field. Pediatric study group of ceftriaxone].
    Fujii R; Meguro H; Arimasu O; Tagaya M; Fujita K; Sakata H; Yoshioka H; Maruyama S; Sanae N; Nagamatsu I
    Jpn J Antibiot; 1986 Aug; 39(8):1988-2008. PubMed ID: 3540338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with sequential intravenous or oral moxifloxacin was associated with faster clinical improvement than was standard therapy for hospitalized patients with community-acquired pneumonia who received initial parenteral therapy.
    Welte T; Petermann W; Schürmann D; Bauer TT; Reimnitz P;
    Clin Infect Dis; 2005 Dec; 41(12):1697-705. PubMed ID: 16288390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fundamental and clinical evaluation on ceftriaxone in the pediatric field].
    Toyonaga Y; Kurosu Y; Uekusa T; Nakamura H; Sugita M; Okabe T; Kawamura K; Seo K; Takahashi T; Hori M
    Jpn J Antibiot; 1984 Nov; 37(11):2060-82. PubMed ID: 6098702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamics of ceftriaxone and cefixime against community-acquired respiratory tract pathogens.
    Owens RC; Tessier P; Nightingale CH; Ambrose PG; Quintiliani R; Nicolau DP
    Int J Antimicrob Agents; 2001 Jun; 17(6):483-9. PubMed ID: 11397619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Discussions on PRSP and BLNAR].
    Tajima T; Meguro H; Akita H; Iwata T
    Jpn J Antibiot; 2001 May; 54 Suppl B():103; discussion 104-6. PubMed ID: 12638161
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bacteriological aspects in the mid term report of the CDTR clinical trial for PRSP and BLNAR infections].
    Ubukata K
    Jpn J Antibiot; 2001 May; 54 Suppl B():91-5. PubMed ID: 12638153
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical evaluation of ceftriaxone in the treatment of neonatal infections].
    Okura K; Yamamoto H; Yamaoka K; Kubo K; Mitsuyoshi I; Haruta T; Kobayashi Y
    Jpn J Antibiot; 1988 Feb; 41(2):152-64. PubMed ID: 3286924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy and safety of twice-daily administration of CTDR].
    Ogata H
    Jpn J Antibiot; 2001 May; 54 Suppl B():98. PubMed ID: 12638156
    [No Abstract]   [Full Text] [Related]  

  • 15. [In vitro resistance rates of Streptococcus pneumoniae and Haemophilus influenzae clinical isolates to the antibiotics used in therapy].
    Uncu H; Colakoğlu S; Turunç T; Demiroğlu YZ; Arslan H
    Mikrobiyol Bul; 2007 Jul; 41(3):441-6. PubMed ID: 17933256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Fundamental and clinical evaluation of ceftriaxone in the field of pediatrics].
    Satoh Y; Iwata S; Akita H; Murai T; Hayano S; Oikawa T; Osano M
    Jpn J Antibiot; 1984 Nov; 37(11):2034-48. PubMed ID: 6098700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [MICs and MBCs of cefotaxime, desacetylcefotaxime and ceftriaxone against four principal bacteria causing meningitis].
    Deguchi K; Fukuyama S; Nishimura Y; Nishike A; Fukumoto T; Oda S; Sato S; Matsumoto Y; Ikegami R; Yokota N
    Jpn J Antibiot; 1984 Sep; 37(9):1701-13. PubMed ID: 6096585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fundamental and clinical evaluation of ceftriaxone in the pediatric field].
    Iwai N; Taneda Y; Shibata M; Mizoguchi F; Katayama M
    Jpn J Antibiot; 1984 Nov; 37(11):2111-30. PubMed ID: 6098705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical efficacy of tebipenem pivoxil treatment in children with pneumonia, who had no relief despite having administered oral beta-lactam antibiotics].
    Sakata H
    Jpn J Antibiot; 2011 Jun; 64(3):171-7. PubMed ID: 21861308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of garenoxacin tablets on bacterial pneumonia: postmarketing surveillance in Japan.
    Izumikawa K; Watanabe A; Miyashita N; Ishida T; Hosono H; Kushimoto S; Kohno S
    J Infect Chemother; 2014 Sep; 20(9):549-57. PubMed ID: 24934887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.